chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pinkish spot at injection site /Pinkish spot 3 inches long 2 inches wide; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011a21) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included SYNTHROID, BABY ASPIRIN, LIPITOR, METOPROLOL, and VITAMINS for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA. At the time of the report, VACCINATION SITE ERYTHEMA outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Excessive menstrual bleeding (more than 1 ultra tampon/hour).  This lasted for 24 hours.
His arm felt numb, rash below the injection site, redness and couldn't move his arm at all, had to use the other arm to move the arm with the injection. Received Doxycycline and Prednisone.
Chills, cramps, leg pain, dizzy, shortness of breath, headache.
the local spasm at the injection site; This is a spontaneous report from a Pfizer sponsored program COVAX US support. A contactable consumer (patient) reported that a male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 18Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced the local spasm at the injection site on 20Apr2021 with outcome of unknown.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This case was reported by a physician via sales rep and described the occurrence of erythema urticarial in a elderly female patient who received SHINGRIX for prophylaxis. Co-suspect products included Flu Seasonal QIV Dresden for prophylaxis. On an unknown date, the patient received SHINGRIX and Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving SHINGRIX and Influenza vaccine Quadrivalent unspecified season, the patient experienced erythema urticarial, skin warm, pain and drug administration error. On an unknown date, the outcome of the erythema urticarial, skin warm, pain and drug administration error were unknown. It was unknown if the reporter considered the erythema urticarial, skin warm and pain to be related to SHINGRIX and Influenza vaccine Quadrivalent unspecified season. Additional details were provided as follows: The age at vaccination was not reported. The patient received flu vaccine (not sure which prescribed) and SHINGRIX in same arm at same time, which led to drug administration error. The patient experienced large red whelp, warm to touch and painful. The reporter did not agree to be contacted for follow up.
Feels like  been hit by a bus; Fever; Chills; fatigued; myalgia; Night sweats; Rash; vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (vaccination site pain), MYALGIA (myalgia), NIGHT SWEATS (Night sweats), FEELING ABNORMAL (Feels like  been hit by a bus) and RASH (Rash) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information reported.  Concomitant products included MAGNESIUM, MULTIVITAMIN [VITAMINS NOS] and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, the patient experienced VACCINATION SITE PAIN (vaccination site pain). On 23-Apr-2021, the patient experienced RASH (Rash). On 24-Apr-2021, the patient experienced MYALGIA (myalgia), NIGHT SWEATS (Night sweats), CHILLS (Chills) and FATIGUE (fatigued). On 10-May-2021, the patient experienced PYREXIA (Fever). On an unknown date, the patient experienced FEELING ABNORMAL (Feels like  been hit by a bus). On 20-Apr-2021, VACCINATION SITE PAIN (vaccination site pain) had resolved. On 27-Apr-2021, RASH (Rash) had resolved. At the time of the report, MYALGIA (myalgia), NIGHT SWEATS (Night sweats), CHILLS (Chills), FATIGUE (fatigued) and PYREXIA (Fever) had not resolved and FEELING ABNORMAL (Feels like  been hit by a bus) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-May-2021, Blood test: (normal) Bloodwork was clean. On 03-May-2021, SARS-CoV-2 test: Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that 5 weeks prior to getting vaccinated, patient reported quitting drinking also patient does not want to get 2nd dose of vaccine Treatment using  Tylenol was reported   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Significant follow up appended to AER MOD21-089100
Experienced immediate intense burning after AVA #3 - worse than other AVA immunizations- that began at the injection site on R anterior arm, went up to R shoulder, into neck, toward occiput, than into L shoulder and down to L hand. R hand ok. This lasted 10 min, real flushed feeling. Resolved except tingling both arms and neck. 4 days later still experiencing tingling in all locations on both arms, back, neck, through both shoulders. No fatigue, but unable to run as he usually does these last couple days due to generalized muscle weakness, aching. No fever, no headache, no depression, no GI symptoms. Feels tightness, muscle feels constricted, sore to move, able to lift R arm with light pain. States injected with AVA in the front of his arm, near the axilla. He is able to work but is very uncomfortable.
Pt. received TDaP right delt 5/16/17 C/O swelling right side of neck - noticed swelling 5/17/17 tender to the touch. Tender and swollen lymph node, R supra-clavicular region since the evening of May 16, 2017, following vaccine admin. Noticed tingling to R fingers, denies loss of function in hand, fingers, arm. Sx's peaked on Wednesday, May 17, 2017 approx. 24 hours after admin with mod pain/R lymphadenopathy and generalized feeling of malaise. Sx's improved starting May 18, 2017 and are progressively better today. Still has mild lymphadenopathy R supra-clavicular node. No other Sx's at this time. Pt. denies fever, chills, body aches or other areas of involvement.
Patient received his 4 year immunizations on 08/07/2018, on 08/30/2018 he developed weakness on his legs and was seen at Hospital ER and admitted, was discharged with diagnosis of a "mental problem". Patient returned to center on 9/5/2018 as a follow-up and he continued with lower extremities weakness and refusing to walk. Patient referred to Hospital, he was admitted and worked up, the Neurologist there thinks he may have Acute Cerebellar Ataxia.
3/24/2021  2:00 pm red hot to the touch rash on left inside of the arm. Muscle twitches all over. Headache the injection site can not be seen no red marks ect 3/25/2021 11:03 am raised red bumps all over neck,back and both arms that were sore even with clothes on.  I took two 25 mg Benadryl at noon and 5 pm...neither dose seemed to help the bumps.  No fever (97.7) but I was and still feel hot it is currently 7:23 pm...still have muscle twitches.  Ongoing headache that I can not get rid of. The injection site is very red  I have pictures if needed
fatigue; nausea; diarrhea; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (fatigue), NAUSEA (nausea) and DIARRHOEA (diarrhea) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, AMLODIPINE and ATORVASTATIN for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced FATIGUE (fatigue), NAUSEA (nausea) and DIARRHOEA (diarrhea). At the time of the report, FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
On the 8th day the injection site became blotchy, red & itchy.  On day 9 the site was solid red and warm to the touch.  On day 10 the redness was gone, but the itch remained until day 12.
Received TDAP, INFLUENZA & TB test x 3 days ago, her (L) supraclavicular lymph node.
Feeling light headed; Burning in neck; This is a spontaneous report from a contactable other healthcare professional. A 45-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EW0217) via intramuscular route, in left arm on an unspecified date (at the age of 45-years-old) as single dose for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included allergies to betadine, latex gloves, septra, lamotrigine, premarine, topamax. Chronic or long-standing health conditions included: migraines, IBS, thyroid, esophagitis. Prescriptions over the counter medications, dietary supplements, herbal remedies being taken at the time of vaccination were not aware of any. Not aware of any for patient other illness at the time of vaccination and up to one month prior. The patient previously received first dose of BNT162B2 (Lot Number: unknown) via an unspecified route of administration on an unspecified date (at the age of 45-years-old) as single dose for COVID-19 immunisation and experienced sore arm and a migraine headache. The patient's concomitant medications were not reported. On an unspecified date, after 2nd dose of Covid vaccine, the patient feeling light-headed and burning in neck. Clinical course included: patient came in for 2nd dose of Covid vaccine, asked patient had first vaccination went, she said sore arm and a migraine headache after but otherwise no problem. Gave patient with no issues and kept her in the area for observation. Patient came back to the counter 5 minutes later feeling light-headed and burning in neck. The event feeling light-headed resulted in emergency room visit. The outcome of the events was unknown.
Patient has history of endometrial uterine ablation nearly 8 years ago.  Interestingly, the day after receiving her Jansen Covid vaccine she had vaginal bleeding which lasted approximately 24 hours. She has not had any vaginal bleeding in the past 8 years since her ablation.  She has also described frequent nosebleeds over the past few days since the vaccination.    Work-up was done in the emergency department including CBC with platelets, D-dimer, coagulation studies, and a complete metabolic panel all which returned 100% normal.  She is well-appearing and unlikely to experience any significant health issues related to the side effect but it seemed worth reporting therefore I am submitting this information.
Patient presents to the clinic for 2nd booster dose of Moderna COVID-19 vaccine. After vaccination verification process and questions, patient mentioned that he has a dexcom blood glucose monitoring system and stated that his blood sugar was 152. RN asked if he had eaten lunch yet and he stated "no, I am usually a late lunch eater and eat around 2pm" it was currently 2:37pm. After administering the vaccine, the patient was discharged to the lobby and as he was walking down the hall he stated he wasn't feeling good and started to feel dizzy. With the help of 2 MAs, we assisted him into the nearest office chair in the hallway near the VS station. The patient pulled out his phone to check his blood sugar and it read 145. VS were as follows: BP 138/83, SPO2 96%, HR 45bmp and climbing, reaching the 80s. Dr. was now in hallway with RN and MAs asking him how he was feeling and A&O questions. Patient now confused, slow to respond, with a decreased level of consciousness. RN waved an ammonia capsule infront of patient's nose with no response. MA applied ice pack to back of patient's neck and cool washcloth to forehead. Dr. now in hallway with previous staff listed. Dr. asked patient if he was having any chest pain. The patient stated yes. The patient also stated that his left arm was hurting. This was the same arm he received the vaccine in and was getting a BP read from. Dr. and Dr. collaborated and stated the patient needed to go to the ER. Staff assisted patient into wheelchair. Dr. called the ER as RN and MA were wheeling the patient and his belongings to the ER. RN and MA took patient through the main ER doors where RN gave report to the ER RNs and assisted them with move of patient to the ER bed where ER staff then assumed cares.
Approx 25 minutes after vaccine, I experienced tingling and fullness of tongue.  I had difficulty swallowing my saliva.  We contacted pharmacy I received the vaccine from and they said to go the fire station across the street.  The symptoms lasted for approx 3 minutes and then subsided.  We went to the fire station and they took vitals and released me, advising me to take Benadryl and go to an urgent care if it came back.  As we were driving home again, I experienced the same thing again.  (Approx 1 hr 25 min after vaccine).  It lasted for 2-3 minutes and then subsided again.  I had lingering numbness of my lower jaw and tip of tongue.  I took 2 Benadryl pills and it relieved all the symptoms.  I slept for 11 hrs.  Upon waking, the numbness of the tongue has persisted.
pt recv vax 12FEB98 & 14FEB98 pt c/o discomfort @ inj site;area was red & warm to touch;APAP given from 12FEB98-present time;15FEB98 arms inc in redness & warmth;16FEB98 areas was worse;mom put warm soaks to area & gave APAP;d, diarrhea;
On Sunday, January 3rd, I woke up to find a rash about 3 inches long, starting at the vaccination site. By Tuesday it had widened. I have photos of both Sunday and Tuesday?s rash, if you would like me to forward those to you. Wednesday night the rash had lightened in color, it was mostly just the outline, but had grown larger than my hand. It crept up towards my shoulder, underarm, and about half way down to my elbow.   Thursday morning (yesterday) I called medical provider to make a Virtual Visit at 5:30pm same day. APRN, called me at about 12:20pm and told me to go to the ER right away. My throat felt swollen and constricted at the time, though I was able to breathe, drink and eat. Swallowing was a bit difficult.  I was seen by PA, at the ER at MC. She evaluated me and said the reaction was bad, but not severe, and on the mend. She prescribed oral prednisone 20mg for the next five days. I did not need any steroid or Benadryl shots. She also said she feels comfortable with me getting the second COVID-19 vaccination, which is scheduled for 1/25.
Mom called on 9/27/04 to report that child's left arm (site of immunization given) was "fiery red and rock hard...just below the shoulder down to his elbow".  Dr. called to verify that child had "non-specific reaction...10-15 cm diameter induration".
Went to give pt flu vaccine in same arm he rec'd flu vaccine in last year (right arm). Noticed a large lump at the site I would give him injection. Pt stated the lump had been there since his flu vaccine last year.
AT FIRST PT SHOWED SOME RASH, LEFT SIDE OF FACE RASH AND SWELLING OF LIP.  THAT WAS ON 6/20/2016. I RECOMMENDED BENADRYL AND CONTINUED MONITORING. PT REPORTED THAT SHE DID WELL ON THE BENADRYL BUT BY MID DAY ON 6/21/2016, PT REPORTED EYE SWELLING, HIP/WAIST RASH. I RECOMMENDED SEEING HER DR AND KEEPING AN EYE ON THE SWELLING IF IT EFFECTED HER THROAT OR BREATHING.  BY 6/23, I SPOKE WITH HER HUSBAND WHO TOLD ME THEY HAD TO GO TO THE ER TO GET TREATMENT FOR SWELLING OF THE FACE, RASH ON SIDES, BACK AND NECK.  PT RECVD PREDNISONE AND CLARITIN FOR THE ALLERGIC REACTION.  TALKED TO PT ON 6/25, SHE SAID ALL OF THE REACTION WAS, FOR THE MOST PART ALL OVER. AGAIN TALKED TO THE PT ON 6/29 AND SHE REPORTED THAT SHE WAS AS GOOD AS NEW.
Feverish Extreme headache Body aches Extreme fatigue Vomiting Diarrhea
Swollen, red, rash, fever, pain. Pain was on 10-24 (1 day after)
Swelling of right thigh x3 days, after vaccine was admin. of DTaP vaccine.
Severe pain at jab site; shoulder (joints), neck and upper back, all localized to left side; This is a spontaneous report from a non-contactable consumer, the patient. A 52-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER COVID-19 mRNA VACCINE BIONTECH, Lot number: EN6206) via an unknown route of administration at left arm on 18Mar2021 at 13:30 (at the age of 52-years) as a single dose for COVID-19 immunisation. The patient had allergy to soy, gluten intolerance, environmental allergies. Concomitant medications included Ibuprofen (MANUFACTURER UNKNOWN) and acetaminophen (MANUFACTURER UNKNOWN) within last two weeks for unknown indications. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested positive for COVID-19 since having the vaccine. Post vaccination, at 21:00, the patient experienced "severe pain at jab site, shoulder (joints), neck and upper back, all localized to left side". The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The treatment received included ice packs under and over arm, on upper back, neck (as reported) for the events vaccination site pain and pain in joint. The clinical outcome of the events vaccination site pain and pain in joint was resolved with sequelae (recovered with lasting effects as reported) on 21Mar2021.  No follow-up attempts are possible. No further information is expected.
headache, dry/scratchy throat, nonproductive cough, fever yesterday 100.4, shortness of breath, sinus congestion, post nasal drainage, wheezing, sneezing.  starting on 10/30/21
Itching and hives, blister rash, swelling at injection site, fevered injection site, vomiting, migraine, body aches, fever and chills Benedryl every 4 hours, Zyrtec BID, Tylenol every 4 hours, Zofran every 6 hours, Toradol inj Still suffering from all of the above
Fever 102F, 7 cm induration/erythema at vaccination site (rt deltoid) - ice, ibuprofen, Tylenol, Benadryl, ABX.
Dtap given, should have been given a Td due to age of patient (10 yo).
High heart rate, low blood pressure, high fever, nausea, fatigue, weakness, headache
30 days p/vax pt malaise;had tenderness in lt arm;tenderness remains unchanged;no palpable hematoma, no redness, no swelling;
Individual started to feel light headed, tongue felt numb, felt hot.  Skin had some light-red blotches around collar-bone.
Lt arm swollen down to wrist next day p/receiving immun on 18DEC89;
being sick; Initial information received on 13-Jan-2023 regarding an unsolicited valid social media non-serious case received from a consumer/ Non-Healthcare Professional (non-hcp).  This case involves an unknown age and unknown gender patient who was being sick after receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received suspect INFLUENZA VACCINE produced by unknown manufacturer (strength, formulation, route, dose: unknown) (lot number and expiry date: not reported) in unknown administration site for prophylactic vaccination (Immunisation).  On an unknown date, the patient developed a non-serious event of being sick (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported, I had the flu shot. Still got "something" this week. Respiratory Syncytial Virus (RSV)? I've had Covid 3 times, and it wasn't that - yes I'm vaccinated and boosted. It is unknown if the patient experienced any additional symptoms/events. It is unknown if the patient had any medical history, concomitant disease or risk factor. It is unknown if there were lab data/results available.   Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (being sick).  At time of reporting, the outcome was Unknown for the event being sick.
Arm Swelling; Decreased Mobility; This case was reported by a pharmacist via call center representative and described the occurrence of swelling arm in a 69-year-old male patient who received Herpes zoster (Shingrix) (batch number BP57E, expiry date 7th December 2021) for prophylaxis.   On 23rd September 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, 7 days after receiving Shingrix, the patient experienced swelling arm (serious criteria hospitalization) and mobility decreased (serious criteria hospitalization). The patient was treated with non-drug therapy (Physiotherapy). On an unknown date, the outcome of the swelling arm and mobility decreased were unknown.   It was unknown if the reporter considered the swelling arm and mobility decreased to be related to Shingrix.  Additional details were provided as follows: The patient received 1st dose Shingrix in right deltoid, and at an unknown time frame following vaccination the patient's arm became swollen and locked up with decreased mobility.  The patient reported to have been hospitalized approximately 1 week following vaccination for 5 days. The patient was undergoing physical therapy.
sore at site 1 day after., headache 9-10 dsys after= generalized rash (itchy)- took benadryl subsided after the 3rd day